Structure and signalling in the IL-17 receptor family
Open accessThe DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Abstract
Interleukin-17A (IL-17A), the hallmark cytokine of the newly defined T helper 17 (T(H)17) cell subset, has important roles in protecting the host against extracellular pathogens, but also promotes inflammatory pathology in autoimmune disease. IL-17A and its receptor (IL-17RA) are the founding members of a newly described family of cytokines and receptors that have unique structural features which distinguish them from other cytokine families. Research defining the signal transduction pathways induced by IL-17R family cytokines has lagged behind that of other cytokine families, but studies in the past 2 years have begun to delineate unusual functional motifs and new proximal signalling mediators used by the IL-17R family to mediate downstream events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“most documented IL-17R signaling occurs in non-hematopoietic cells, particularly cells of epithelial and mesenchymal origin [44,45].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Cited by
Items 901–1,000 of 1,001
IL ‐25 Enhances B Cell Responses in Type 2 Inflammation Through IL ‐ 17RB Receptor
Abdu, S., Jiao, X., Yuan, H., Tan, T. J., Layhadi, J. A., Shamji, M. H., McKenzie, A. N. J., Haloob, N., Hopkins, C. L., Woszczek, G., et al. (2025) · Allergy · doi:10.1111/all.16472 · Cited by 19
“IL-17RA serves as a common receptor subunit for other IL-17 cytokine family members such as IL-17A and IL-17F which signal through a heterodimeric receptor complex composed of IL-17RA and IL-17RC [40].”
Secukinumab for the Treatment of Psoriasis in Pediatrics: Patient Selection and Acceptability
Narbutt, J., Niedźwiedź, M., Lesiak, A., Ceryn, J., & Skibińska, M. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s350753 · Cited by 17
“Genomic sequencing has led to the identifications of six IL-17 subtypes, IL-17A, B, C, D, E (also known as IL-25), and IL-17F, of which both IL-17A and IL-17F are most homologous (55%) and seem to be most important in psoriatic pathological pathways.(38,41,42) Physiologically, IL-17A takes part in many phenomena, such…”
BackgroundSpinal astrocyte-derived interleukin-17A promotes pain hypersensitivity in bone cancer mice
Liu, H., Lv, X., Zhao, X., Yi, L., Lü, N., Xu, W., & Zhang, Y. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.09.016 · Cited by 16
“IL-17RA mediates the biological function of IL-17A signaling 18 .”
Bédard-Matteau, J., Soulé, A., Liu, K. Y., Fourcade, L., Fraser, D. D., Emad, A., & Rousseau, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1452788 · Cited by 16
Guo, X., Jiang, X., Xiao, Y., Zhou, T., Guo, Y., Wang, R., Zhao, Z. J., He, X., Hou, C., Ma, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089714 · Cited by 16
“Act1 (transcription factor NF-k B activator 1) is an important adaptor protein in IL-17 receptor (IL-17R) signaling and IL-17Adependent immune responses [36].”
BackgroundThe Cannabinoid 2 Receptor as a Potential Therapeutic Target for Sepsis
Kasten, K. R., Tschöp, J., Tschöp, M. H., & Caldwell, C. C. (2010) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153010791936874 · Cited by 17
Rationalizing heptadecaphobia: TH17 cells and associated cytokines in cancer and metastasis
Lücke, J., Shiri, A. M., Zhang, T., Kempski, J., Giannou, A. D., & Huber, S. (2021) · FEBS Journal · doi:10.1111/febs.15711 · Cited by 14
Immunodeficiency and Autoantibodies to Cytokines
Knight, V. (2021) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab139 · Cited by 16
Biologics for Psoriasis During the COVID-19 Pandemic
Zeng, H., Wang, S., Chen, L., & Shen, Z. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.759568 · Cited by 17
“The IL-17 family includes six IL-17-family ligands [IL-17A, IL-17B, IL-17C, IL-17D, IL-17E (IL-25), and IL-17F], and five receptors (IL-17RA, IL-17RB/IL-25R, IL-17RC, IL-17RD/SEF, and IL-17RE) (28).”
BackgroundKeogh, K. A., Waters, S. M., Cormican, P., Kelly, A. K., & Kenny, D. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194445 · Cited by 15
Ahn, I. E., Ju, J. H., Lee, S., Park, J. S., Oh, H., Kim, H. R., Lee, S. H., Park, S. H., Kim, H. Y., & Cho, M. L. (2012) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2012.02745.x · Cited by 16
Pușcaș, A. D., Catana, A. M., Pușcaș, C., Roman, I., Vornicescu, C., Şomlea, M., & Orăsan, R. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7624 · Cited by 24
Konermann, A., Winter, J., Novak, N., Allam, J., & Jäger, A. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.10.004 · Cited by 17
Act1, Scene Brain: Astrocytes Play a Lead Role
Rodgers, J. M., Zhou, L. F., & Miller, S. D. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.009 · Cited by 16
“A variety of cells express the IL-17R signaling complex, facilitating inflammatory responses to locally produced IL-17 in most tissues (Gaffen, 2009).”
BackgroundYang, Z., Wang, T., Wang, B., Gao, H., He, C., Shang, H., Lü, X., Wang, Y., & Xu, J. (2022) · Journal of Inflammation · doi:10.1186/s12950-022-00311-0 · Cited by 15
“IL-17+ γδ T cells (γδ17 T cells), natural killer cells, and T helper 17 (Th17) cells are the well-known providers of IL-17A in various models of inflammatory diseases [57, 58].”
BackgroundMonocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritis
Iwasaki, T., Watanabe, R., Ito, H., Fujii, T., Ohmura, K., Yoshitomi, H., Murata, K., Murakami, K., Ōnishi, A., Tanaka, M., et al. (2024) · Arthritis Research & Therapy · doi:10.1186/s13075-023-03236-y · Cited by 17
“IL17A is known to modulate both expression of TLR5 and IL17RA [33, 34].”
Geoghegan, K. F., Song, X., Hoth, L. R., Feng, X., Shanker, S., Quazi, A., Luxenberg, D. P., Wright, J. F., & Griffor, M. C. (2012) · Protein Expression and Purification · doi:10.1016/j.pep.2012.09.013 · Cited by 14
Horvath, D. J., Radin, J. N., Cho, S. H., Washington, M. K., & Algood, H. M. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060363 · Cited by 15
“to consist of homodimers or heterodimers [20,21].”
Vidlak, D., & Kielian, T. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-128 · Cited by 18
“Because IL-17, IL-17E, and IL-17F all signal via the IL-17R [9,30,31], analysis of IL-17R knockout (KO) mice”
BackgroundMori, K., Fujisawa, T., Kusagaya, H., Yamanaka, K., Hashimoto, D., Enomoto, N., Inui, N., Nakamura, Y., Maekawa, M., & Suda, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139491 · Cited by 14
“IL-17A is well known for its protective properties during bacterial infections and its involvement in autoimmune diseases [12].”
BackgroundMerkel cell polyomavirus and Langerhans cell neoplasm
Murakami, I., Wada, N., Nakashima, J., Iguchi, M., Toi, M., Hashida, Y., Higuchi, T., Daibata, M., Matsushita, M., Iwasaki, T., et al. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0261-y · Cited by 16
Cytokines as Mediators of Neuroinflammation in Experimental Autoimmune Encephalomyelitis
Gogoleva, V. S., Атретханы, К.-С. Н., Drutskaya, M. S., Mufazalov, I. A., Kruglov, A., & Nedospasov, S. A. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918090110 · Cited by 14
Interleuquina-17A: posible mediador y diana terapéutica en la hipertensión
Rodrigues-Díez, R. R., Tejera‐Muñoz, A., Orejudo, M., Márquez‐Expósito, L., dos Santos, L. J., Rayego‐Mateos, S., Cantero‐Navarro, E., Tejedor-Santamaria, L., Marchant, V. A., Ortíz, A., et al. (2021) · Nefrología · doi:10.1016/j.nefro.2020.11.009 · Cited by 20
Gatsiou, A., Sopova, K., Tselepis, A. D., & Stellos, K. (2021) · Cells · doi:10.3390/cells10081855 · Cited by 17
“IL-17A is a potent proinflammatory cytokine that acts on fibroblasts, stromal, epithelial, endothelial cells, as well as on monocytes, stimulating the secretion of proinflammatory mediators, including chemokines like CXCL1, CXCL5, CXCL8 (IL-8), CXCL12 (SDF-1) and CCL2 (MCP1) [48,49]; cytokines, like tumour necrosis fa…”
BackgroundZhang, Y., Song, J., Jiang, J., Yin, S., Luo, Y., Luo, Y., Ding, X., Ru, Y., Liu, L., Li, W., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114485 · Cited by 14
Bertol, B. C., de Araújo, J. N. G., de Carvalho, K. T. C., dos Santos, M. G., Martelli‐Palomino, G., de Figueiredo-Feitosa, N. L., Maciel, L. M. Z., Silbiger, V. N., Lucena‐Silva, N., Freitas, J. C. D. O. C., et al. (2021) · Archives of Medical Research · doi:10.1016/j.arcmed.2021.07.004 · Cited by 16
Sass, D., Saligan, L. N., Fitzgerald, W., Berger, A. M., Torres, I., Barb, J. J., Kupzyk, K. A., & Margolis, L. B. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01554-w · Cited by 17
“All three cytokines share a common signaling pathway through the NFκB complex: IFNα2 increases NFκB activity through IFN-induced genes [31], IL-17 leads to the activation of NFκB [32], and NFkB has been implicated in the expression of IL-9 [33].”
BackgroundDysregulated thrombospondin 1 and miRNA-29a-3p in severe COVID-19
Kim, I. S., Lee, S., Shin, S. G., Jeong, H., Sohn, K. M., Park, K.-S., Silwal, P., Cheon, S., Kim, J., Kym, S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-23533-x · Cited by 15
Expression, refolding and purification of a human interleukin-17A variant
Wu, B., Nemeth, J. F., Janecki, D. J., Jones, B. H., Obmolova, G., Malia, T., Baker, A. E., Bethea, D., Elloso, M. M., Naso, M. F., et al. (2010) · Cytokine · doi:10.1016/j.cyto.2010.07.002 · Cited by 15
IL-4 Induces IL17Rb Gene Transcription in Monocytic Cells with Coordinate Autocrine IL-25 Signaling
Weathington, N. M., Kanth, S. M., Gong, Q., Londino, J. D., Hoji, A., Rojas, M. M., Trudeau, J. B., Wenzel, S. E., & Mallampalli, R. K. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0316oc · Cited by 15
Keramat, F., Kazemi, S., Saidijam, M., Zamani, A., Kohan, H. F., Mamani, M., Eini, P., Moghimbigi, A., & Alikhani, M. Y. (2019) · Microbiology and Immunology · doi:10.1111/1348-0421.12675 · Cited by 14
IL-17A-producing γδ T cells promote liver pathology in acute murine schistosomiasis
Sun, L., Gong, W., Shen, Y., Liang, L., Zhang, X., Li, T., Chen, T. T., Hu, Y., & Cao, J. (2020) · Parasites & Vectors · doi:10.1186/s13071-020-04200-4 · Cited by 15
Jiang, B., Li, Y., Hu, Y., Luo, H., & Li, A. (2017) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2017.08.010 · Cited by 14
Garg, A. V., & Gaffen, S. L. (2013) · Cell Cycle · doi:10.4161/cc.26699 · Cited by 14
Self-citationDai, H., Sheng, X., Wang, Y., Zhou, L., Lin, Y., Du, Y., Yang, F., Sha, R., Peng, J., Yao, L., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.729965 · Cited by 16
“It is a cytokine family composed of six interleukins (IL-17A to F) with the ability to promote inflammation (Gaffen, 2009).”
BackgroundJAK Inhibitors for the Treatment of Axial Spondyloarthritis
Klavdianou, K., Papagoras, C., & Baraliakos, X. (2023) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.34.2.129 · Cited by 17
“On the other hand, although the “signature cytokines” of AxSpA, i.e. IL-17 12–15 Indeed, data from animal models suggest a link connecting JAKis and the IL-23/IL-17 axis and therefore could at least partially explain the efÏcacy of this drug class in psoriatic arthritis (PsA) and SpA.”
BackgroundInfluentialWang, X., Wang, T., Jiang, X., Ruan, Y., Wang, J., & Qi, C. (2024) · Medicine · doi:10.1097/md.0000000000037153 · Cited by 13
Anyfanti, P., Angeloudi, E., Dara, A., Pagkopoulou, E., Moysidou, G.-S., Deuteraiou, K., Boutel, M., Bekiari, E., Doumas, M. N., Kitas, G. D., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14080834 · Cited by 14
“Although IL-17 does not seem directly modulated by the JAK/STAT system [24], the function of IL-23, which is an upstream driver of IL-17A release, is regulated by the JAK2–TYK2/STAT3–STAT4 system [25,26].”
BackgroundUnveiling the role of IL-17: Therapeutic insights and cardiovascular implications
Jiang, K., Xu, Y., Wang, Y., Yin, N., Huang, F., & Chen, M. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.05.001 · Cited by 14
Yu, Y., Shen, H., Qin, Q., Wang, J., Nie, Y., Wen, L., Tang, Y., & Qu, M. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2024.12.057 · Cited by 13
TH17 Cells Are Critical for Skin-Specific Pathological Injury in Acute Graft-Versus-Host Disease
Cheng, H., Tian, J., Li, Z., Zeng, L., Pan, B., Song, G., Chen, W., & Xu, K. (2012) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.12.078 · Cited by 17
Su, S.-B., Zhang, J., Huang, F., Cen, Y., & Jiang, H. (2017) · Microbiology and Immunology · doi:10.1111/1348-0421.12500 · Cited by 13
“The biological function of IL17 depends on its homo- or heterodimer composition from six possible proteins, designated IL-17A-F (18).”
BackgroundVroman, H. H., Das, T., Bergen, I. M., van Hulst, J. A. C., Ahmadi, F., Loo, G., Lubberts, E., Hendriks, R. W., & Kool, M. (2018) · Clinical & Experimental Allergy · doi:10.1111/cea.13262 · Cited by 13
“IL‐17RA/C heterodimer is used by IL‐17A, IL‐17F and IL‐17A/F and the IL‐17RA/B heterodimer is activated by IL‐17E (also known as IL‐25).19 Ablation of the IL‐17RA subunit will therefore affect the signalling of IL‐17A, IL‐17F, IL‐17A/F and IL‐25.”
BackgroundMethodInfluentialMetabolic regulation of innate immunity
Liang, S., Ji, L., Kang, L., & Hu, X. (2019) · Advances in immunology · doi:10.1016/bs.ai.2019.11.005 · Cited by 14
Rocher, B. D., Binato, R., de‐Freitas‐Junior, J. C. M., Corrêa, S., Mencalha, A. L., Morgado‐Díaz, J. A., & Abdelhay, E. S. F. W. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10051-4 · Cited by 14
Cho, B., Lim, J., Yahng, S., Lee, S., Eom, K., Kim, Y., Chung, N. G., Jeong, D.-C., Lee, S., Kim, H., et al. (2011) · Annals of Hematology · doi:10.1007/s00277-011-1318-9 · Cited by 13
Insulin Resistance and Serum Levels of Interleukin-17 and Interleukin-18 in Normal Pregnancy
Jahromi, A. S., Shojaei, M., & Ghobadifar, M. A. (2014) · Immune Network · doi:10.4110/in.2014.14.3.149 · Cited by 13
“Although, we did not find any study in medicine literature to show the association of IL-17 and IL-18 with insulin resistance during pregnancy, but our findings were in contrast with previous studies which showed the significant roles of IL-17 and IL-18 on insulin resistance in non pregnant population (29-31).”
ResultQi, Y., Zheng, H., Liu, N., Guo, T., Zhu, W., Wang, S., Cui, B., & Ning, G. (2015) · Clinical Endocrinology · doi:10.1111/cen.12725 · Cited by 15
New Approaches for Studying Alcoholic Liver Disease
Xu, J., Liu, X., Gao, B., Karin, M., Tsukamoto, H., Brenner, D. A., & Kisseleva, T. (2014) · Current Pathobiology Reports · doi:10.1007/s40139-014-0053-z · Cited by 13
Shi, G., Li, S. J., Wang, T. T., Cheng, C. M., Fan, Y., & Zhu, K. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15038357 · Cited by 13
“Hence, CARD14 mutation may result in an amplified inflammatory response upon epidermal activation, and lead more readily to lesion development (Gaffen, 2009).”
BackgroundHalofugine prevents cutaneous graft versus host disease by suppression of Th17 differentiation
Cheng, H., Tian, J., Zeng, L., Pan, B., Li, Z., Song, G.-L., Chen, W., & Xu, K. (2012) · Hematology · doi:10.1179/1607845412y.0000000016 · Cited by 14
A Truncated IL‐17RC Peptide Ameliorates Synovitis and Bone Destruction of Arthritic Mice
Du, Y., Tong, Y., Mei, W., Jia, J., Niu, M., Cao, W., Lou, W., Li, S., Li, Z., Stinson, W. A., et al. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600668 · Cited by 13
Miao, M., Yan, J., Sun, Y., Liu, J., & Guo, S. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s506103 · Cited by 17
Xing, C., Duan, T., Li, L., Chen, L., Zhang, P., Du, Y., Liu, S., Annaparthi, N., Wang, S., Chen, Q., et al. (2025) · Science Advances · doi:10.1126/sciadv.ads3530 · Cited by 16
“…to IL-17A, the IL-17RA/IL-17RC complex recruits and activates ACT1 (also known as CIKS, encoded by TRAF3IP2 ), which, in turn, phosphorylates tumor necrosis factor receptor–associated factor 6 (TRAF6) and triggers TRAF6-dependent transcription of C/EBP β and other downstream targets ( 38 ).”
Liu, M., Lu, B., Fan, H., Guo, X., Du, S., Yang, D., Xu, Y., Li, Y., Che, D., Liu, Y., et al. (2021) · Mediators of Inflammation · doi:10.1155/2021/9955168 · Cited by 14
Leal-Silva, T., Lopes, C. D. A., Vieira-Santos, F., Oliveira, F. M. S., Kraemer, L. R., Padrão, L. D. L. S., Amorim, C. C. O., Souza, J. L. N., Russo, R. C., Fujiwara, R. T., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.864632 · Cited by 14
“IL-17 family cytokines mediate effects at the molecular level by binding to their receptors, known as IL-17R family receptors (IL-17RA - IL-17RE), which have unique structural characteristics and trigger signaling events (4).”
BackgroundShaw, D. J., Waters, L. C., Strong, S. L., Schulze, M. E. D., Greetham, G. M., Towrie, M., Parker, A. W., Prosser, C. E., Henry, A. J., Lawson, A. D. G., et al. (2023) · Chemical Science · doi:10.1039/d3sc00728f · Cited by 12
Interaction of Interleukin-17A with a Th2 Response in a Mouse Model of Allergic Airway Inflammation
Peters, K., Ernst, S., & Peters, M. (2023) · Cells · doi:10.3390/cells12131774 · Cited by 13
“Moreover, it has been described that the affinity of IL-17RC to IL-17F is higher than to IL-17A [29,30].”
BackgroundNoghabi, P. G., Shahini, N., Salimi, Z., Ghorbani, S., Bagheri, Y., & Derakhshanpour, F. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06032-3 · Cited by 14
“To date, six ligands of the IL-17 family [IL-17 A, IL-17B, IL-17 C, IL-17D, IL-17E (IL-25), and IL-17 F] and five receptors (IL-17RA, IL-17RB/ IL-25R, IL-17RC, IL-17RD/SEF, and IL-17RE) have been identified [14, 15].”
BackgroundSong, Z., Li, J., & Gong, X. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156416 · Cited by 12
Montaño, R. R., Alarcón‐Sánchez, M. A., Martínez, S. M. L., Martínez‐Bugarin, C. H., & Heboyan, A. G. (2025) · Immunity Inflammation and Disease · doi:10.1002/iid3.70147 · Cited by 14
The role of IL-17 in the treatment of psoriatic arthritis
Lubrano, E., & Perrotta, F. M. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1327354 · Cited by 12
Xu, Z.-L., Li, S.-R., Fu, L., Zheng, L., Ye, J., & Li, J. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.04.026 · Cited by 14
Interleukin 17, the double-edged sword in atherosclerosis
Moeinafshar, A., Razi, S., & Rezaei, N. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152220 · Cited by 13
Enevold, C., Loft, N., Bregnhøj, A., Zachariae, C. O. C., Iversen, L., Skov, L., & Nielsen, C. H. (2022) · JAMA Dermatology · doi:10.1001/jamadermatol.2022.1863 · Cited by 12
The nature of innate and adaptive interleukin‐17A responses in sham or bacterial inoculation
Chong, D. L. W., Ingram, R. J., Lowther, D. E., Muir, R., Sriskandan, S., & Altmann, D. M. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03584.x · Cited by 12
Unmet Needs in the Treatment of Rheumatoid Arthritis
Pope, J. E., & Combe, B. G. (2013) · Open Journal of Rheumatology and Autoimmune Diseases · doi:10.4236/ojra.2013.32011 · Cited by 14
“Brodalumab (previously AMG-827) differs mechanistically from secukinumab and ixekizumab; it is a fully human monoclonal antibody directed against IL-17RA [106], which is a subunit of the receptor through which IL-17A produces its biological effects [87,107].”
BackgroundIL-17RA in Intestinal Inflammation: Structure, Signaling, Function, and Clinical Application
Liu, S., Ren, J., & Li, J. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000217 · Cited by 14
“It has been suggested that the strength of IL-17A–mediated signaling is associated with the cell surface expression level of IL-17RA.3 Also, a high expression level of IL-17RA is required for effective responses to IL-17A.3 This brings forward a possible hypothesis that IL-17A produced by Th17 cells and IL-17RA expres…”
BackgroundInfluentialTan, J., Lei, L., Chen, X.-T., Ding, P., Wu, Y., & Chen, L. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7315 · Cited by 14
Feng, Y., Zhou, Z., Liu, Z., Zheng, C., Feng, F., Xie, F., & Wu, Z. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02366-1 · Cited by 13
“participates in neutrophil recruitment, autoimmune disease, and extracellular pathogen immunity [9].”
BackgroundImmunological Mechanisms Underlying Allergy Predisposition After SARS-CoV-2 Infection in Children
Filippatos, F., Matara, D.-I., Michos, A. G., & Kakleas, K. (2025) · Cells · doi:10.3390/cells14191511 · Cited by 12
“[150] TSLP/IL-25/IL-33 (triad) Often act in concert when epithelial damage occurs.”
Deng, H., Liu, Q., Yu, S., Zhong, L., Gan, L., Gu, H., Wang, Q., Cheng, R., Liu, Y., Liu, L., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.03.014 · Cited by 15
Chen, S., Fan, H., Ran, C., Hong, Y., Feng, H., Yue, Z., Zhang, H., Pontarotti, P., Xu, A., & Huang, S. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2400903121 · Cited by 13
The neuroimmune mechanism of pain induced depression in psoriatic arthritis and future directions
Wang, X., Wu, L., Liu, J., Ma, C., Liu, J., & Zhang, Q. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117802 · Cited by 13
Ji, Y., Zhao, Z., Yang, Y., Wang, X., Qiao, R., Yu, X., Gong, X., Feng, Z., & Hong, Q. (2025) · Research · doi:10.34133/research.0738 · Cited by 23
“IL-17A (hereafter referred to as IL-17) transmits biological signals by binding to IL-17 receptor A (IL-17RA) and IL-17 receptor C (IL-17RC) [ 78 ].”
MODERN IDEA ON THE PATHOGENESIS OF SPONDYLOARTHRITIS: MOLECULAR MECHANISMS
Nasonov, E. L., Galushko, E. A., & Gordeev, A. V. (2015) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2015-299-307 · Cited by 14
Kui, L., Kong, Q., Yang, X., Pan, Y., Xu, Z., Wang, S., Chen, J., Wei, K., Zhou, X., Yang, X., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.684351 · Cited by 14
The Association of IL-17 and PlGF/sENG Ratio in Pre-Eclampsia and Adverse Pregnancy Outcomes
Darmochwał-Kolarz, D., & Chara, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20010768 · Cited by 12
“Interleukin-17 (IL-17, also known as IL-17A) is a major, strongly proinflammatory cytokine produced by Th17 helper cells [14].”
BackgroundAnti-gout and Urate-lowering Potentials of Curcumin: A Review from Bench to Beside
Jafari‐Nozad, A. M., Jafari, A., Yousefi, S., Bakhshi, H., Farkhondeh, T., & Samarghandian, S. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230721154653 · Cited by 13
No effect of anti-TNF-α treatment on serum IL-17 in patients with rheumatoid arthritis
Sikorska, D., Rutkowski, R., Łuczak, J., Samborski, W., & Witowski, J. (2018) · Central European Journal of Immunology · doi:10.5114/ceji.2018.80045 · Cited by 11
“In this respect IL-17(A) is thought to be an inducer of inflammation, while IL-17F is implicated in chronic inflammation [32, 33].”
BackgroundRole of IL-17A and neutrophilic granulocytes in the pathogenesis of psoriasis
Smolyannikova, V. A., Karamova, A. Е., & Nefedova, M. A. (2020) · Russian Journal of Archive of Pathology · doi:10.17116/patol20208201130 · Cited by 13
Fernández‐Albarral, J. A., Martínez‐López, M. A., Marco, E. M., de Hoz, R., Martín‐Sánchez, B., Felipe, D. S., Salobrar‐García, E., López‐Cuenca, I., Pinazo-Duran, M. D., Salazar, J. J., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10214801 · Cited by 11
“IL-17 can induce neuroinflammation by recruiting T-helper-17 lymphocytes, which are highly related to the inflammatory response in autoimmune pathologies [77].”
BackgroundXu, J.-G., Jia, H., Chen, S., Xu, J., Zhan, Y., Yu, H., Wang, W., Kang, X., Cui, X., Feng, Y., et al. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.01.119 · Cited by 12
Rehman, T., Pezzulo, A. A., Thurman, A. L., Zemans, R. L., & Welsh, M. J. (2024) · JCI Insight · doi:10.1172/jci.insight.181836 · Cited by 13
In vitro/In vivo Evaluations of Hydroxyapatite Nanoparticles with Different Geometry
Sun, W., Zhong, J., Gao, B., Feng, J. Q., Ye, Z., Lin, Y., Zhang, K., Su, W., Zhu, S., Li, Y., et al. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s469687 · Cited by 13
Antinociceptive interactions between excitatory interferon-γ and interleukin-17 in sensory neurons
Natura, G., Vazquez, E., Richter, F., von Banchet, G. S., Ebbinghaus, M., Ebersberger, A., König, C., Maltritz, J., Gajda, M. R., Schmidt‐Hieber, C., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.11.021 · Cited by 10
Gautam, A. S., Pandey, S. K., Balki, S., Panda, E. S., & Singh, R. K. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10192-8 · Cited by 12
Gao, Y., Sang, F. F., Meng, D. L., Wang, Y., Ma, W. T., & Chen, D. K. (2019) · BMC Biotechnology · doi:10.1186/s12896-019-0543-5 · Cited by 10
T cell transgressions: Tales of T cell form and function in diverse disease states
Harris, K. M., Clements, M. A., Kwilasz, A. J., & Watkins, L. R. (2021) · International Reviews of Immunology · doi:10.1080/08830185.2021.1921764 · Cited by 12
“IL-17A and IL-17F share a common receptor, IL-17RA, with IL-17A binding with high affinity [62,63].”
BackgroundRoles of Interleukin-17 and Th17 Responses in COVID-19
Kang, Y. W., Lee, S. C., Jeon, S., & Jo, E. (2021) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2021.51.3.089 · Cited by 14
“IL-17 includes unique structures composed of IL-17A and IL-17F (17); it is an inducer of antimicrobial proteins, various chemokines, acute-phase response mediators, and inflammatory functions (16, 19).”
BackgroundA Mechanistic Insight into the Pathogenic Role of Interleukin 17A in Systemic Autoimmune Diseases
Bisoendial, R. J., & Lubberts, E. (2022) · Mediators of Inflammation · doi:10.1155/2022/6600264 · Cited by 12
“Amongst the five canonical IL-17 receptors, named IL-17RA to RE, IL-17A signals as a homodimer IL-17A/A via the heterodimeric IL-17RA/RC receptor complex, which may also be engaged by the homodimer IL-17F/ F (IL-17F) and the IL-17A/IL-17F heterodimer (IL-17A/F) [1] (see Figure 1).”
BackgroundInfluentialWankhede, A. N., & Dhadse, P. (2022) · Journal of Indian Society of Periodontology · doi:10.4103/jisp.jisp_47_21 · Cited by 15
Du, S., Wang, H., Zhang, Y., Liu, Z., Zhao, H.-C., & Zhang, Y. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s84092 · Cited by 12
Evolution of prokaryotic homologues of the eukaryotic SEFIR protein domain
Wu, B., Gong, J., Liu, L., Li, T., Wei, T., & Bai, Z. (2011) · Gene · doi:10.1016/j.gene.2011.10.033 · Cited by 12
Auger, J. L., Cowan, H. M., Engelson, B. J., Kashem, S. W., Prinz, I., & Binstadt, B. A. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39646 · Cited by 12
“Each of these cytokine dimers signals through the IL-17 receptor (IL-17R) comprising IL-17RA and IL-17RC subunits (3).”
BackgroundA Review Article on Brodalumab in the Treatment of Moderate-To-Severe Plaque Psoriasis
Roostaeyan, O., Kivelevitch, D. N., & Menter, A. (2017) · Immunotherapy · doi:10.2217/imt-2017-0077 · Cited by 11
Characterization and Functional Study on Octopus ocellatus Interleukin-17
Li, Z., Fan, T., Liu, X., Liu, X., Wang, W., Wang, Q., You, L., Wang, L., Wei, X., & Yang, J. (2019) · Journal of Ocean University of China · doi:10.1007/s11802-019-4116-y · Cited by 10
“…that IL-17 family and their receptor family have little homology to any other known cytokines and receptors, indicating that they have a distinct ligand-receptor signaling system that appears to be highly conservative among vertebrates (Kawaguchi et al., 2004; Gaffen, 2009; Wu et al., 2013).”
BackgroundThe IL-17 receptor IL-17RE mediates polyIC-induced exacerbation of experimental allergic asthma
Vella, G., Lunding, L. P., Ritzmann, F., Honecker, A., Herr, C., Wegmann, M., Bals, R., & Beißwenger, C. (2020) · Respiratory Research · doi:10.1186/s12931-020-01434-9 · Cited by 10
Carpentieri, A., Mascia, P., Fornaro, M., Beylot-Barry, M., Taïeb, A., Foti, C., & Loconsole, F. (2020) · Dermatologic Therapy · doi:10.1111/dth.14044 · Cited by 10
Discovery of novel immunopharmacological ligands targeting the IL-17 inflammatory pathway
Álvarez-Coiradas, E., Munteanu, C. R., Saez, L. D., Pazos, A., Huber, K., Loza, M. I., & Domínguez, E. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107026 · Cited by 12
Metadata
- Authors
- Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Gaffen, Sarah L.
- ORCID
- Gaffen, Sarah L.
- Venue
- Nature reviews. Immunology
- Published
- 2009-07-03
- Volume
- 9
- Issue
- 8
- Pages
- 556-567
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2821718
- OpenAlex
- W2020233428
- Cited by
- 1,475
- References
- 111
- Citations by year
- 2026: 66 · 2025: 87 · 2024: 57 · 2023: 76 · 2022: 80 · 2021: 118 · 2020: 76 · 2019: 96 · 2018: 81 · 2017: 92 · 2016: 108 · 2015: 91 · 2014: 107 · 2013: 89 · 2012: 90
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Update notices
- erratum (2009-08-07)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR054389)
- National Institute of Dental and Craniofacial Research (R21DE018822)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-17A, IL-17RA, Th17 cells, cytokine signaling, signal transduction, innate and adaptive immunity, autoimmune disease, inflammatory pathology
- MeSH terms
- Animals, Autoimmune Diseases, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Signal Transduction, Cytokines, Interleukin-17, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.